Φορτώνει......
sCLU regulates cisplatin chemosensitivity of lung cancer cells in vivo
BACKGROUND: In a previous analysis using a lung cancer cell line model, we have found that therapies directed against secreted clusterin (sCLU) and its downstream signaling targets pAkt and pERK1/2 may have the potential to enhance the efficacy of cisplatin (DDP)-based chemotherapy in vitro. Here, w...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | World J Surg Oncol |
|---|---|
| Κύριοι συγγραφείς: | , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
BioMed Central
2015
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4358856/ https://ncbi.nlm.nih.gov/pubmed/25884382 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12957-015-0501-1 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|